News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Julie Kissack, PharmD, BCPP, FCCP

Articles by Julie Kissack, PharmD, BCPP, FCCP

(Taking Pills) ©Sheff/Shutterstock.com

QTc Prolongation Associated With Psychotropics: Therapeutic Considerations

ByMegan B. McCorkle, BA,Nicole B. Washington, DO,Nancy C. Brahm, PharmD, MS, BCPP, CGP,Julie Kissack, PharmD, BCPP, FCCP

March 18th 2016

A focus on QTc monitoring in patients receiving psychotropics, especially when multiple medications are prescribed.

Latest Updated Articles

QTc Prolongation Associated With Psychotropics: Therapeutic Considerations
Published: March 18th 2016 | Updated:

Trending on Psychiatric Times

A New and Improved DSM? The American Psychiatric Association Shares Strategy and Roadmap

The Psychopharmacology of Personality Disorders

Retention in Care: The Good, the Bad, and the Ugly

One Year After the President’s Inauguration